Fabiano Svolacchia, Lorenzo Svolacchia, Patrizia Falabella, Carmen Scieuzo, Rosanna Salvia, Fabiana Giglio, Alessia Catalano, Carmela Saturnino, Pierpaolo Di Lascio, Giuseppe Guarro, Giusy Carmen Imbriani, Giuseppe Ferraro, Federica Giuzio
Background and Objectives : This three-year clinical trial aimed to demonstrate that only the signaling vesicles produced by ADSCa, containing mRNA, microRNA, growth factors (GFs), and bioactive peptides, provide an advantage over classical therapy with adipose disaggregate to make the tissue regeneration technique safer due to the absence of interfering materials and cells, while being extremely minimally invasive. The infiltration of disaggregated adipose nanofat, defined by the Tonnard method, for the regeneration of the dermis and epidermis during physiological or pathological aging continues to be successfully used for the presence of numerous adult stem cells in suspension (ADSCa)...
April 21, 2024: Medicina